Cargando…
Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer
An increased level of interleukin-6 (IL-6) in epithelial ovarian cancer (EOC) is correlated with a worse prognosis. IL-6 stimulates tumor-growth and inflammation. We investigated the intricate interaction between the IL-6 signaling pathway and tumor-infiltrating myeloid cells (TIMs) to determine the...
Autores principales: | Wouters, MCA, Dijkgraaf, EM, Kuijjer, ML, Jordanova, ES, Hollema, H, Welters, MJP, van der Hoeven, JJM, Daemen, T, Kroep, JR, Nijman, HW, van der Burg, SH |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353164/ https://www.ncbi.nlm.nih.gov/pubmed/25964862 http://dx.doi.org/10.4161/21624011.2014.962397 |
Ejemplares similares
-
Immunologic aspect of ovarian cancer and p53 as tumor antigen
por: Nijman, HW, et al.
Publicado: (2005) -
Interleukin‐6‐mediated resistance to immunotherapy is linked to impaired myeloid cell function
por: Beyranvand Nejad, Elham, et al.
Publicado: (2020) -
A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer
por: Dijkgraaf, Eveline M., et al.
Publicado: (2015) -
Interleukin-6 and ratio of plasma interleukin-6/interleukin-10 as risk factors of symptomatic lumbar osteoarthritis
por: Suyasa, I Ketut, et al.
Publicado: (2017) -
Opposite effects of interleukin-4 and interleukin-10 on nitric oxide production in murine macrophages
por: Maru, A., et al.
Publicado: (1996)